Besilate — supply status, manufacturers & alternatives

Besilate

—

🇦🇺 AUST R 302294 · Pharmacor Pty Ltd

In supply · Australia

Nimbex

In supply · 🇦🇺 Australia

In supply in Australia

No active shortage reported.

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Besilate
Brand names	Nimbex
Therapeutic category	Auto-created by Thai FDA — National Drug Information shortage bulletin scraper
Controlled substance	No

Registrations on file	25

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 2 resolved events

◷

45–46 months

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🌐

NDI-TH · 1h ago

Resolved

Verified timeline regulator events

🌐 6 Oct 2022

Shortage resolved

🌐 6 Sept 2022

Shortage resolved

Sources official regulators

🌐

NDI-TH

verified 1h ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders25 registrations · 3 MA holders

Product	Strength	Form	Market	MA holder	Status
Pharmacor Olmesartan Amlodipine	20 mg	—	🇦🇺 AU	Pharmacor Pty Ltd	Active
NOUMED AMLODIPINE amlodipine	10 mg	—	🇦🇺 AU	—	Active
Olmesart Amlo Hct	40 mg	—	🇦🇺 AU	—	Active
Olmetan Amlo Hct	40 mg	—	🇦🇺 AU	—	Active
Olmes Amlo Hct	40 mg	—	🇦🇺 AU	—	Active
Olmesartan Amlo Hct Gppl	40 mg	—	🇦🇺 AU	—	Active
Olmesartan Amlodipine - Wgr	20 mg	—	🇦🇺 AU	—	Active
Apo-Olmesartan/Amlodipine	40 mg	—	🇦🇺 AU	—	Active
APX-AMLODIPINE amlodipine	5 mg	—	🇦🇺 AU	—	Active
Olmesartan Amlodipine - Wgr	40 mg	—	🇦🇺 AU	—	Active
BTC AMLODIPINE amlodipine	5 mg	—	🇦🇺 AU	—	Active
BTC AMLODIPINE amlodipine	10 mg	—	🇦🇺 AU	—	Active
Olmekar	40 mg	—	🇦🇺 AU	—	Active
APX-AMLODIPINE amlodipine	10 mg	—	🇦🇺 AU	—	Active
Olmes Amlo Hct	20 mg	—	🇦🇺 AU	—	Active

+10 more registrations on file

Mederti Drug Report

Generated 3 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.